Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

New Diagnostic Criteria for Obesity

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Fatal Arrhythmias – The Patterns GPs Don’t Want to Miss

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Prof Andrew Sindone

Prof Andrew Sindone

How to Use the BNP Test in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024